Volokhina EB - Search Results

1

Shiga Toxin Selectively Upregulates Expression of Syndecan-4 and Adhesion Molecule ICAM-1 in Human Glomerular Microvascular Endothelium.

Volokhina EB, Feitz WJC, Elders LM, van der Velden TJAM, van de Kar NCAJ, van den Heuvel LPWJ. Volokhina EB, et al. Toxins (Basel). 2020 Jul 3;12(7):435. doi: 10.3390/toxins12070435. Toxins (Basel). 2020. PMID: 32635212 Free PMC article.

2

Genetic disorders in complement (regulating) genes in patients with atypical haemolytic uraemic syndrome (aHUS).

Westra D, Volokhina E, van der Heijden E, Vos A, Huigen M, Jansen J, van Kaauwen E, van der Velden T, van de Kar N, van den Heuvel L. Westra D, et al. Nephrol Dial Transplant. 2010 Jul;25(7):2195-202. doi: 10.1093/ndt/gfq010. Epub 2010 Jan 26. Nephrol Dial Transplant. 2010. PMID: 20106822

3

A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome.

Westra D, Wetzels JF, Volokhina EB, van den Heuvel LP, van de Kar NC. Westra D, et al. Among authors: volokhina eb. Neth J Med. 2012 Apr;70(3):121-9. Neth J Med. 2012. PMID: 22516576 Free article. Review.

4

Atypical hemolytic uremic syndrome and genetic aberrations in the complement factor H-related 5 gene.

Westra D, Vernon KA, Volokhina EB, Pickering MC, van de Kar NC, van den Heuvel LP. Westra D, et al. Among authors: volokhina eb. J Hum Genet. 2012 Jul;57(7):459-64. doi: 10.1038/jhg.2012.57. Epub 2012 May 24. J Hum Genet. 2012. PMID: 22622361 Free PMC article.

5

Novel C3 mutation p.Lys65Gln in aHUS affects complement factor H binding.

Volokhina E, Westra D, Xue X, Gros P, van de Kar N, van den Heuvel L. Volokhina E, et al. Pediatr Nephrol. 2012 Sep;27(9):1519-24. doi: 10.1007/s00467-012-2183-z. Epub 2012 Jun 6. Pediatr Nephrol. 2012. PMID: 22669319 Free PMC article.

6

Analysis of rare variants in the C3 gene in patients with age-related macular degeneration.

Duvvari MR, Paun CC, Buitendijk GH, Saksens NT, Volokhina EB, Ristau T, Schoenmaker-Koller FE, van de Ven JP, Groenewoud JM, van den Heuvel LP, Hofman A, Fauser S, Uitterlinden AG, Klaver CC, Hoyng CB, de Jong EK, den Hollander AI. Duvvari MR, et al. Among authors: volokhina eb. PLoS One. 2014 Apr 15;9(4):e94165. doi: 10.1371/journal.pone.0094165. eCollection 2014. PLoS One. 2014. PMID: 24736606 Free PMC article.

7

Complement activation patterns in atypical haemolytic uraemic syndrome during acute phase and in remission.

Volokhina EB, Westra D, van der Velden TJ, van de Kar NC, Mollnes TE, van den Heuvel LP. Volokhina EB, et al. Clin Exp Immunol. 2015 Aug;181(2):306-13. doi: 10.1111/cei.12426. Clin Exp Immunol. 2015. PMID: 25079699 Free PMC article.

8

Sensitive, reliable and easy-performed laboratory monitoring of eculizumab therapy in atypical hemolytic uremic syndrome.

Volokhina EB, van de Kar NC, Bergseth G, van der Velden TJ, Westra D, Wetzels JF, van den Heuvel LP, Mollnes TE. Volokhina EB, et al. Clin Immunol. 2015 Oct;160(2):237-43. doi: 10.1016/j.clim.2015.05.018. Epub 2015 Jun 23. Clin Immunol. 2015. PMID: 26111482 Free article.

9

Eculizumab treatment efficiently prevents C5 cleavage without C5a generation in vivo.

Volokhina EB, Bergseth G, van de Kar NC, van den Heuvel LP, Mollnes TE. Volokhina EB, et al. Blood. 2015 Jul 9;126(2):278-9. doi: 10.1182/blood-2015-03-637645. Blood. 2015. PMID: 26160188 Free PMC article. No abstract available.

10

Fecal diagnostics in combination with serology: best test to establish STEC-HUS.

Wijnsma KL, van Bommel SA, van der Velden T, Volokhina E, Schreuder MF, van den Heuvel LP, van de Kar NC. Wijnsma KL, et al. Pediatr Nephrol. 2016 Nov;31(11):2163-70. doi: 10.1007/s00467-016-3420-7. Epub 2016 May 30. Pediatr Nephrol. 2016. PMID: 27240858 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page